Breaches of the pial basement membrane are associated with defective dentate gyrus development in mouse models of congenital muscular dystrophies

Neuroscience Letters

Volumn 505, Issue 1, 2011, Pages 19-24

  Li, Jing ^a   Yu, Miao ^a   Feng, Gang ^b   Hu, Huaiyu ^a   Li, Xiaofeng ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Basement membrane; Brain development; Congenital muscular dystrophies; Dentate gyrus

Indexed keywords

ARTICLE; ASTROCYTE; BASEMENT MEMBRANE; CONTROLLED STUDY; DENTATE GYRUS; ECTOPIC TISSUE; ELECTRON MICROSCOPY; FOREBRAIN; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MESENCEPHALON; MUSCULAR DYSTROPHY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; STAINING; WILD TYPE;

ANIMALS; BASEMENT MEMBRANE; DENTATE GYRUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HOMEODOMAIN PROTEINS; MANNOSYLTRANSFERASES; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCULAR DYSTROPHIES; N-ACETYLGLUCOSAMINYLTRANSFERASES; PIA MATER; TUMOR SUPPRESSOR PROTEINS;

EID: 82455167931     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.09.040     Document Type: Article

References (37)

1. Haltia M., Leivo I., Somer H., Pihko H., Paetau A., Kivela T., Tarkkanen A., Tome F., Engvall E., Santavuori P. Muscle-eye-brain disease: a neuropathological study. Ann. Neurol 1997, 41:173-180.
2. van der Knaap M.S., Smit L.M., Barth P.G., Catsman-Berrevoets C.E., Brouwer O.F., Begeer J.H., de C., Valk I.J. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann. Neurol. 1997, 42:50-59.
3. Lian G., Sheen V. Cerebral developmental disorders. Curr. Opin. Pediatr. 2006, 18:614-620.
4. Dobyns W.B., Kirkpatrick J.B., Hittner H.M., Roberts R.M., Kretzer F.L. Syndromes with lissencephaly. II: Walker-Warburg and cerebro-oculo-muscular syndromes and a new syndrome with type II lissencephaly. Am. J. Med. Genet. 1985, 22:157-195.
5. Ross M.E., Walsh C.A. Human brain malformations and their lessons for neuronal migratio. Annu. Rev. Neurosci. 2001, 24:1041-1070.
6. Parano E., Pavone L., Fiumara A., Falsaperla R., Trifiletti R.R., Dobyns W.B. Congenital muscular dystrophies: clinical review and proposed classification. Pediatr. Neurol. 1995, 13:97-103.
7. Jimenez-Mallebrera C., Brown S.C., Sewry C.A., Muntoni F. Congenital muscular dystrophy: molecular and cellular aspects. Cell Mol. Life Sci. 2005, 62:809-823.
8. Golden J.A. Cell migration and cerebral cortical development. Neuropathol. Appl. Neurobiol. 2001, 27:22-28.
9. Beltran-Valero de B.D., Currier S., Steinbrecher A., Celli J., van B.E., van der Z.B., Kayserili H., Merlini L., Chitayat D., Dobyns W.B., Cormand B., Lehesjoki A.E., Cruces J., Voit T., Walsh C.A., van B.H., Brunner H.G. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 2002, 71:1033-1043.
10. van Reeuwijk J., Janssen M., van den Elzen C., Beltran-Valero de B.D., Sabatelli P., Merlini L., Boon M., Scheffer H., Brockington M., Muntoni F., Huynen M.A., Verrips A., Walsh C.A., Barth P.G., Brunner H.G., van Bokhoven H. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J. Med. Genet. 2005, 42:907-912.
11. Yoshida A., Kobayashi K., Manya H., Taniguchi K., Kano H., Mizuno M., Inazu T., Mitsuhashi H., Takahashi S., Takeuchi M., Herrmann R., Straub V., Talim B., Voit T., Topaloglu H., Toda T., Endo T. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 2001, 1:717-724.
12. Kobayashi K., Nakahori Y., Miyake M., Matsumura K., Kondo-Iida E., Nomura Y., Segawa M., Yoshioka M., Saito K., Osawa M., Hamano K., Sakakihara Y., Nonaka I., Nakagome Y., Kanazawa I., Nakamura Y., Tokunaga K., Toda T. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998, 394:388-392.
13. Longman C., Brockington M., Torelli S., Jimenez-Mallebrera C., Kennedy C., Khalil N., Feng L., Saran R.K., Voit T., Merlini L., Sewry C.A., Brown S.C., Muntoni F. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet. 2003, 12:2853-2861.
14. Currier S.C., Lee C.K., Chang B.S., Bodell A.L., Pai G.S., Job L., Lagae L.G., Al-Gazali L.I., Eyaid W.M., Enns G., Dobyns W.B., Walsh C.A. Mutations in POMT1 are found in a minority of patients with Walker-Warburg syndrome. Am. J. Med. Genet. A 2005, 133:53-57.
15. de Bernabe D.B., van B.H., van B.E., Van den A.W., Kant S., Dobyns W.B., Cormand B., Currier S., Hamel B., Talim B., Topaloglu H., Brunner H.G. A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype. J. Med. Genet. 2003, 40:845-848.
16. Brockington M., Yuva Y., Prandini P., Brown S.C., Torelli S., Benson M.A., Herrmann R., Anderson L.V., Bashir R., Burgunder J.M., Fallet S., Romero N., Fardeau M., Straub V., Storey G., Pollitt C., Richard I., Sewry C.A., Bushby K., Voit T., Blake D.J., Muntoni F. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 2001, 10:2851-2859.
17. Brockington M., Blake D.J., Prandini P., Brown S.C., Torelli S., Benson M.A., Ponting C.P., Estournet B., Romero N.B., Mercuri E., Voit T., Sewry C.A., Guicheney P., Muntoni F. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 2001, 69:1198-1209.
18. Liu J., Ball S.L., Yang Y., Mei P., Zhang L., Shi H., Kaminski H.J., Lemmon V.P., Hu H. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech. Dev. 2006, 123:228-240.
19. Hu H., Li J., Gagen C.S., Gray N.W., Zhang Z., Qi Y., Zhang P. Conditional knockout of protein O-mannosyltransferase 2 reveals tissue specific roles of O-mannosyl glycosylation in brain development. J. Comp Neurol. 2011, 519:1320-1337.
20. Holzfeind P.J., Grewal P.K., Reitsamer H.A., Kechvar J., Lassmann H., Hoeger H., Hewitt J.E., Bittner R.E. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders. Hum. Mol. Genet. 2002, 11:2673-2687.
21. Liu J., Zhang L., Wang D., Shen H., Jiang M., Mei P., Hayden P.S., Sedor J.R., Hu H. Congenital diaphragmatic hernia, kidney agenesis and cardiac defects associated with Slit3-deficiency in mice. Mech. Dev. 2003, 120:1059-1070.
22. Yang Y., Zhang P., Xiong Y., Li X., Qi Y., Hu H. Ectopia of meningeal fibroblasts and reactive gliosis in the cerebral cortex of the mouse model of muscle-eye-brain disease. J. Comp Neurol. 2007, 505:459-477.
23. Kano H., Kobayashi K., Herrmann R., Tachikawa M., Manya H., Nishino I., Nonaka I., Straub V., Talim B., Voit T., Topaloglu H., Endo T., Yoshikawa H., Toda T. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 2002, 291:1283-1286.
24. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., Dollar J., Nishino I., Kelley R.I., Somer H., Straub V., Mathews K.D., Moore S.A., Campbell K.P. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002, 418:417-422.
25. Kim D.S., Hayashi Y.K., Matsumoto H., Ogawa M., Noguchi S., Murakami N., Sakuta R., Mochizuki M., Michele D.E., Campbell K.P., Nonaka I., Nishino I. POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG. Neurology 2004, 62:1009-1011.
26. Grewal P.K., Holzfeind P.J., Bittner R.E., Hewitt J.E. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet. 2001, 28:151-154.
27. Takeda S., Kondo M., Sasaki J., Kurahashi H., Kano H., Arai K., Misaki K., Fukui T., Kobayashi K., Tachikawa M., Imamura M., Nakamura Y., Shimizu T., Murakami T., Sunada Y., Fujikado T., Matsumura K., Terashima T., Toda T. Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development. Hum. Mol. Genet. 2003, 12:1449-1459.
28. Montanaro F., Lindenbaum M., Carbonetto S. alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J. Cell Biol. 1999, 145:1325-1340.
29. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 1993, 122:809-823.
30. Yamada H., Shimizu T., Tanaka T., Campbell K.P., Matsumura K. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett. 1994, 352:49-53.
31. Gee S.H., Montanaro F., Lindenbaum M.H., Carbonetto S. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 1994, 77:675-686.
32. Yamada H., Denzer A.J., Hori H., Tanaka T., Anderson L.V., Fujita S., Fukuta-Ohi H., Shimizu T., Ruegg M.A., Matsumura K. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J. Biol. Chem. 1996, 271:23418-23423.
33. Peng H.B., Ali A.A., Daggett D.F., Rauvala H., Hassell J.R., Smalheiser N.R. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes. Commun. 1998, 5:475-489.
34. Talts J.F., Andac Z., Gohring W., Brancaccio A., Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 1999, 18:863-870.
35. Sato S., Omori Y., Katoh K., Kondo M., Kanagawa M., Miyata K., Funabiki K., Koyasu T., Kajimura N., Miyoshi T., Sawai H., Kobayashi K., Tani A., Toda T., Usukura J., Tano Y., Fujikado T., Furukawa T. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat. Neurosci. 2008, 11:923-931.
36. Hu H., Yang Y., Eade A., Xiong Y., Qi Y. Breaches of the Pial Basement Membrane and Disappearance of the Glia Limitans during Development Underlie the Cortical Lamination Defect in the Mouse Model of Muscle-eye-brain Disease. J. Comp Neurol. 2007, 501:168-183.
37. Li X., Zhang P., Yang Y., Xiong Y., Qi Y., Hu H. Differentiation and developmental origin of cerebellar granule neuron ectopia in POMGnT1 knockout mice. Neurosci. 2008, 152:391-406.